Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
Unknown status
Grewal Eye Institute
Phase 4
2007-05-01
This study analyzes the safety and efficacy of off-label Subconjunctival Injection of
bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following
glaucoma filtration surgery.
The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A
Completed
Assistance Publique - Hôpitaux de Paris
Phase 3
2008-09-01
Second line treatment for detrusor hyperreflexia is the intravesical BTX-A injections. First
300 units Botox are diluted with 30 ml of preservative-free saline. Using a rigid cystoscope
and an injection needle, BTX-A is injected into 30 sites within the detrusor muscle.
The used of KALINOX® (50% nitrous oxide and oxygen) inhalation has demonstrated analgesic
efficacy in various procedures (obstetric, liver biopsy, transrectal ultrasound guided
prostate biopsy, emergency) The aim of this study is to investigate the safety and efficacy
of analgesia with N2O/O2 inhalation for detrusor BTX-A injections using a rigid cystoscope.
Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Unknown status
Allergan
N/A
2013-07-01
The purpose of this study is to determine whether there is a change in patient-reported
pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of
normal saline.
Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Unknown status
Boston Urogynecology Associates
N/A
2013-07-01
The purpose of this study is to determine whether there is a change in patient-reported
pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of
normal saline.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
